Dilution of Per-Share Value Due to Stock Option Exercise
First written in FY2016. 17 of 23 entries say "Materialised", first in FY2017-Q1. Latest entry: 2026-07-30.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- 2026-07-30MaterialisedEarnings
「Third quarter of the fiscal year ending September 2026 31,784,200 shares Fiscal year ended September 2025 31,759,000 shares」
Shares issued increased by 25,200 from 31,759,000 in the prior-year period to 31,784,200, continuing the increase in the share count. - FY2026-H1MaterialisedAnnual report
「1 October 2025–31 March 2026 (Note) 20,000 31,779,000 33 2,949 33 2,897 (Note) Increase resulting from the exercise of stock acquisition rights.」
20,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of shares issued to 31,779,000. Some of the potential dilution has materialized as actual share issuance. - 2026-04-30MaterialisedEarnings
「Fiscal year ending September 2026 interim period 31,779,000 shares Fiscal year ended September 2025 31,759,000 shares」
The number of shares issued at the end of the period increased by 20,000 from the end of September of the previous year, and proceeds from the issuance of new shares were recorded. Some potential dilution factors have appeared as an increase in the share count. - FY2025-H1WorsenedAnnual report
「17th Stock Options Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 413,400 (Note 1) 18th Stock Options Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 16,100 (Note 1)」
The issuance of the 17th and 18th stock options added a total of 429,500 potential shares. In addition to dilution from exercises already carried out, a new source of dilution has materialized through actual issuance. - FY2023MaterialisedAnnual report
「28 July 2023 30,000 31,759,000 22,545 2,916,189 22,545 2,905,939 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
30,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of shares issued to 31,759,000. Some of the potential dilution has materialized as actual share issuance. - FY2023-Q3MaterialisedAnnual report
「Common shares 31,729,000 31,759,000 Tokyo Stock Exchange (Prime Market)」
Issued shares increased from 31,729,000 at the end of the third-quarter accounting period to 31,759,000 as of the filing date, an increase of 30,000 shares. The company continues to indicate the materialisation of a dilution factor through an increase in issued shares that may include shares issued upon the exercise of stock acquisition rights. - FY2023-Q2MaterialisedAnnual report
「Funds obtained from financing activities amounted to ¥124 million, compared with an outflow of ¥30 million in the same quarter of the previous year. This represented proceeds from the issuance of stock acquisition rights.」
Proceeds of ¥124 million from the issuance of stock acquisition rights were recognised, concretely evidencing a new dilution factor associated with potential shares through an actual issuance. The balance of stock acquisition rights also increased from ¥277.842 million to ¥561.976 million. - FY2023-Q1WorsenedAnnual report
「15th stock options Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 272,300 (Note) 1 16th stock options Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 5,600 (Note) 1」
The issuance of new stock options added a total of 277,900 potential shares. In addition to dilution from the exercise of existing stock acquisition rights, the factors that may dilute shareholder value in the future have expanded. - FY2022MaterialisedAnnual report
「13 June 2022 12,000 31,729,000 9,018 2,893,644 9,018 2,883,394 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
The exercise of stock acquisition rights resulted in the issuance of 12,000 shares, bringing total issued shares to 31,729,000. Part of the potential dilution factor materialised through an actual share issuance. - FY2022-Q3MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 12,000 31,729,000 9,018 2,893,644 9,018 2,883,394 (Note) The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights in the third quarter resulted in the issuance of 12,000 shares, bringing total issued shares to 31,729,000. Part of the potential dilution factor materialised through an actual share issuance. - FY2021MaterialisedAnnual report
「All increases in common shares resulted from the exercise of stock acquisition rights. The decreases in the 8th, 9th and 12th stock acquisition rights resulted from their cancellation after acquisition. The decrease in the 10th stock acquisition rights resulted from the exercise of rights and their cancellation after acquisition. The decrease in the 11th stock acquisition rights resulted from the exercise of rights.」
During the fiscal year, common shares increased by 507,000 through the exercise of stock acquisition rights. Exercises of the 10th and 11th rights, among others, actually occurred, and part of the potential dilution factor materialised through share issuance. - FY2021-Q3MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 130,000 31,717,000 97,695 2,884,626 97,695 2,874,376 (Note) The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 130,000 shares, bringing total issued shares to 31,717,000. Part of the dilution factor materialised through an actual share issuance. - FY2021-Q2MaterialisedAnnual report
「Funds provided by financing activities amounted to ¥607.397 million, compared with no cash flow in the same quarter of the previous year. This represented proceeds from the exercise of the 10th and 11th stock acquisition rights and the issuance of the 13th and 14th stock acquisition rights.」
The exercise of the 10th and 11th stock acquisition rights and the issuance of the 13th and 14th stock acquisition rights were recognised as cash inflows, with part of the dilution factor in shareholder value progressing to actual exercise and issuance. - FY2021-Q1MaterialisedAnnual report
「377,000 31,587,000 283,315 2,786,931 283,315 2,776,681 (Note) The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights in the first quarter resulted in the issuance of 377,000 shares, bringing total issued shares to 31,587,000. Part of the potential dilution factor materialised through an actual share issuance. - FY2020WorsenedAnnual report
「Directors of our company 2 people 95 units (9,500 shares) Employees of our company 37 people 731 units (73,100 shares) Common shares 82,600 shares」
The 13th paid stock options added 82,600 potential shares for directors and employees, and the 14th added 6,700 potential shares for subsidiary employees, expanding the dilution factor. - FY2019MaterialisedAnnual report
「12th stock acquisition rights Common shares 119,200 Total 948,500」
The 119,200 shares covered by the 12th stock acquisition rights were added, increasing the number of potential shares from 829,300 to 948,500. A new dilution factor has materialised through an actual issuance. - FY2019-Q2MaterialisedAnnual report
「Funds provided by financing activities amounted to ¥51.620 million, an increase of ¥30.334 million year on year. This represented proceeds from the issuance of the 12th stock acquisition rights.」
Proceeds of ¥51.620 million from the issuance of the 12th stock acquisition rights were recognised, concretely evidencing a new dilution factor associated with potential shares through an actual issuance. - FY2019-Q1MaterialisedAnnual report
「Number of stock acquisition rights (units)* 1,192 (Note) 1 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 119,200 (Note) 1」
The 12th stock acquisition rights were issued, creating new potential shares covering 119,200 shares. - FY2018MitigatedAnnual report
「As of the end of the consolidated fiscal year under review, the number of potential shares represented by stock acquisition rights was 829,300, equivalent to 5.3% of the total number of issued shares of 15,605,000.」
The number and ratio of potential shares decreased from 1,261,300 shares and 8.3% to 829,300 shares and 5.3%, respectively. In addition, subsequent events included a decision to issue the 12th paid stock options covering 119,200 shares. - FY2018-Q1MaterialisedAnnual report
「1 October 2017–31 December 2017 432,000 15,605,000 12,372 2,503,615 12,372 2,493,365 (Note) The increase resulted from the exercise of stock acquisition rights.」
The issuance of 432,000 shares through the exercise of stock acquisition rights materialised part of the potential dilution in shareholder value. - FY2017WorsenedAnnual report
「As of the end of the consolidated fiscal year under review, the number of potential shares represented by stock acquisition rights was 1,261,300, equivalent to 8.3% of the total number of issued shares of 15,173,000.」
The number and ratio of potential shares increased from 960,800 shares and 6.8% to 1,261,300 shares and 8.3%, respectively. Meanwhile, the exercises of the 1st through 5th stock acquisition rights had been completed, and those of the 6th and 7th had also been completed by the end of the month preceding the filing date, meaning that dilution had partly materialised. - FY2017-Q1MaterialisedAnnual report
「1 October 2016–31 December 2016 264,000 14,368,000 6,696 462,321 6,696 452,071 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
The issuance of 264,000 shares through the exercise of stock options materialised part of the potential dilution risk. - FY2016First statedAnnual report
「As of the end of the fiscal year under review, the number of potential shares represented by stock acquisition rights was 960,800, equivalent to 6.8% of the total number of issued shares of 14,104,000.」
The company discloses 960,800 potential shares represented by stock acquisition rights, equivalent to 6.8% of total issued shares, indicating the potential for dilution upon exercise.